INS and Alzheimer disease: Herewith, we aim to review some aspects of the current knowledge of the exciting field of AD pathophysiology, focusing on reports that point to insulin signaling in the central nervous system (CNS) as a novel and promising pathogenic and therapeutic field of inquiry.